Nos publications

Les équipes du CRCM publient chaque année plus de 130 articles de recherche fondamentale, translationnelle et clinique.

En direct

Photo de profil par défault
Sep 2021 ChemMedChem

Revisiting the Molecular Interactions between the Tumor Protein TCTP and the Drugs Sertraline/Thioridazine.

Malard F, Jacquet E, Nhiri N, Sizun C, Chabrier A, Messaoudi S, Dejeu J, Betzi S, Zhang X, Thureau A, Lescop E

Photo de profil par défault
Aug 2021 Molecular microbiology

Characterization of TseB, a new actor in cell wall elongation in Bacillus subtilis.

Delisle J, Cordier B, Audebert S, Pophillat M, Cluzel C, Espinosa L, Grangeasse C, Galinier A, Doan T

Photo de profil par défault
Aug 2021 Journal of cell science

Insights into animal septins using recombinant human septin octamers with distinct SEPT9 isoforms.

Iv F, Martins CS, Castro-Linares G, Taveneau C, Barbier P, Verdier-Pinard P, Camoin L, Audebert S, Tsai FC, Ramond L, Llewellyn A, Belhabib M, Nakazawa K, Di Cicco A, Vincentelli R, Wenger J, Cabantous S, Koenderink GH, Bertin A, Mavrakis M

Photo de profil par défault
Aug 2021 mBio

Inhibiting Type VI Secretion System Activity with a Biomimetic Peptide Designed To Target the Baseplate Wedge Complex.

Cherrak Y, Filella-Merce I, Schmidt V, Byrne D, Sgoluppi V, Chaiaheloudjou R, Betzi S, Morelli X, Nilges M, Pellarin R, Durand E

Jul 2021 Biomedicines

Antisense Oligonucleotide-Based Therapeutic against Menin for Triple-Negative Breast Cancer Treatment.

Nguyen DT, Le TK, Paris C, Cherif C, Audebert S, Udu-Ituma SO, Benizri S, Barthélémy P, Bertucci F, Taïeb D, Rocchi P

Photo de profil par défault
Jun 2021 Cell death & disease

TNF-α induces endothelial-mesenchymal transition promoting stromal development of pancreatic adenocarcinoma.

Adjuto-Saccone M, Soubeyran P, Garcia J, Audebert S, Camoin L, Rubis M, Roques J, Binétruy B, Iovanna JL, Tournaire R

Photo de profil par défault
Jun 2021 Nature

Concerted cutting by Spo11 illuminates meiotic DNA break mechanics.

Johnson D, Crawford M, Cooper T, Claeys Bouuaert C, Keeney S, Llorente B, Garcia V, Neale MJ

Photo de profil par défault
Jun 2021 Proceedings of the National Academy of Sciences of the United States of America

High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome.

Chretien AS, Devillier R, Granjeaud S, Cordier C, Demerle C, Salem N, Wlosik J, Orlanducci F, Gorvel L, Fattori S, Hospital MA, Pakradouni J, Gregori E, Paul M, Rochigneux P, Pagliardini T, Morey M, Fauriat C, Dulphy N, Toubert A, Luche H, Malissen M, Blaise D, Nunès JA, Vey N, Olive D

Photo de profil par défault
May 2021 Oncoimmunology

Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors.

Bertucci F, Boudin L, Finetti P, Van Berckelaer C, Van Dam P, Dirix L, ViensP, Gonçalves A, Ueno NT, Van Laere S, Birnbaum D, Mamessier E

Photo de profil par défault
May 2021 Genome medicine

Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial.

Bertucci F, Gonçalves A, Guille A, Adelaïde J, Garnier S, Carbuccia N, BillonE, Finetti P, Sfumato P, Monneur A, Pécheux C, Khran M, Brunelle S, Mescam L,Thomassin-Piana J, Poizat F, Charafe-Jauffret E, Turrini O, Lambaudie E,Provansal M, Extra JM, Madroszyk A, Gilabert M, Sabatier R, Vicier C, MamessierE, Chabannon C, Pakradouni J, Viens P, André F, Gravis G, Popovici C, BirnbaumD, Chaffanet M